Overview

The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection

Status:
Completed

Trial end date:
2022-03-03

Target enrollment:

Participant gender:

Summary

Phase IV, single-center, open study to assess the benefits of the start of immediate treatment without immunovirological data ("Same Day Treatment") compared to conventional treatment with BIC / FTC / TAF in naive patients with type 1 HIV (human immunodeficiency virus) infection

Phase:

Phase 4

Details

Lead Sponsor:

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Treatments:

Emtricitabine
Tenofovir